Target-specific drug release to the colon

被引:40
作者
Jain, Sanjay K. [1 ]
Jain, Anekant [1 ]
机构
[1] Dr Hari Singh Gour Vishwavidyalaya, Dept Pharmaceut Sci, Pharmaceut Res Projects Lab, Sagar 470003, MP, India
关键词
biodegradable polymers; colon delivery; colon drug delivery system; colonic microlflora;
D O I
10.1517/17425247.5.5.483
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The ability to deliver drugs to the human colon in a specific manner has become feasible over the years. Targeting pharmaceutical drugs to the colon makes it possible to achieve local or systemic drug delivery to this site. Objective: To deliver the compounds in a non-degraded form to the lower part of the gastrointestinal tract, they must first pass through the stomach and the upper part of the intestine before releasing the contents in the colon. Methods: This review provides an overview of the various approaches to targeted drug delivery to the colon using different drug delivery systems, their limitations and the future developments in this field. Results/conclusions: A microbially controlled system, which is a well-accepted approach, based on natural polymers, has the greatest potential for colonic delivery, particularly in terms of site specificity and safety. However, close attention should be paid to the performance of these products in the heterogeneous environment of the human gastrointestinal tract.
引用
收藏
页码:483 / 498
页数:16
相关论文
共 113 条
[21]   FATE OF BETA-CYCLODEXTRIN IN THE HUMAN INTESTINE [J].
FLOURIE, B ;
MOLIS, C ;
ACHOUR, L ;
DUPAS, H ;
HATAT, C ;
RAMBAUD, JC .
JOURNAL OF NUTRITION, 1993, 123 (04) :676-680
[22]  
FOX DA, 1991, M OR DEL PROT PEPT O
[23]  
Friend DR, 1998, ALIMENT PHARM THER, V12, P591
[24]   COLON-SPECIFIC DRUG DELIVERY [J].
FRIEND, DR .
ADVANCED DRUG DELIVERY REVIEWS, 1991, 7 (01) :149-199
[25]   RELATIVE ANTIINFLAMMATORY EFFECT OF ORAL DEXAMETHASONE-BETA-D-GLUCOSIDE AND DEXAMETHASONE IN EXPERIMENTAL INFLAMMATORY BOWEL-DISEASE IN GUINEA-PIGS [J].
FRIEND, DR ;
PHILLIPS, S ;
MCLEOD, A ;
TOZER, TN .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1991, 43 (05) :353-355
[26]   DRUG GLYCOSIDES IN ORAL COLON-SPECIFIC DRUG DELIVERY [J].
FRIEND, DR ;
TOZER, TN .
JOURNAL OF CONTROLLED RELEASE, 1992, 19 (1-3) :109-120
[27]   An in vitro investigation of the suitability of press-coated tablets with hydroxypropylmethylcellulose acetate succinate (HPMCAS) and hydrophobic additives in the outer shell for colon targeting [J].
Fukui, E ;
Miyamura, N ;
Kobayashi, M .
JOURNAL OF CONTROLLED RELEASE, 2001, 70 (1-2) :97-107
[28]   Preparation of enteric coated timed-release press-coated tablets and evaluation of their function by in vitro and in vivo tests for colon targeting [J].
Fukui, E ;
Miyamura, N ;
Uemura, K ;
Kobayashi, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 204 (1-2) :7-15
[29]  
Gardner D., 1997, PHARM TECHNOL, V21, P82
[30]  
GAZZANIGA A, 1995, STP PHARMA SCI, V5, P83